| For Practicing Oncologists |
See all
 | Articles: Lung/Thoracic Oncology |
Randomized phase II trial comparing amrubicin with topotecan in patients with previously treated small-cell lung cancer: North Japan Lung Cancer Study Group Trial 0402
Journal of Clinical Oncology, 11/21/08
|
| | Sponsor |
Randomized phase II study of vandetanib alone or with paclitaxel and carboplatin as first-line treatment for advanced non–small-cell lung cancer
Journal of Clinical Oncology, 11/21/08
Effect of BRCA1 haplotype on survival of non-small cell lung cancer patients treated with platinum-based chemotherapy
Journal of Clinical Oncology, 11/21/08
[18F]Fluorothymidine Positron Emission Tomography before and 7 Days after Gefitinib Treatment Predicts Response in Patients with Advanced Adenocarcinoma of the Lung
Clinical Cancer Research, 11/21/08
Prognostic Significance of Epithelial-Mesenchymal and Mesenchymal-Epithelial Transition Protein Expression in Non–Small Cell Lung Cancer
Clinical Cancer Research, 11/21/08
The Use of Genetic Markers to Identify Lung Cancer in Fine Needle Aspiration Samples
Clinical Cancer Research, 11/21/08
Towards customized therapy for non small cell lung cancer
Bulletin du Cancer, 11/21/08
Pleomorphic carcinoma of the lung expressing podoplanin and calretinin
Pathology International, 11/21/08
Evaluation of EGFR abnormalities in patients with pulmonary adenocarcinoma: the need to test neoplasms with more than one method
Modern Pathology, 11/21/08


Genetic Predictors of MEK Dependence in Non–Small Cell Lung Cancer
Cancer Research, 11/20/08
|
Receive daily email updates on Lung/Thoracic Oncology
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
250 Available Pages
 |
|
|
| Sponsor |
|
 |
Read a Different Specialty |
|
|
|
|
 |
Profession Index
|
|
|
|
|
 |
|
|
|
| Sponsor |
|
|
| Sponsor |
|